| Thu, May 14, 2009 | | • | ORTHOLOGIC CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Thu, May 14)
| | Wed, May 13, 2009 | | • | ORTHOLOGIC CORP Financials
EDGAR Online Financials (Wed, May 13)
| | Tue, May 12, 2009 | | • | Capstone reports loss, lays off 7
at bizjournals.com (Tue, May 12)
| | Mon, May 11, 2009 | | • | Q1 2009 Capstone Therapeutics Earnings Release - Time Not Supplied
CCBN (Mon, May 11)
| | • | ORTHOLOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, May 11)
| | • | Capstone Therapeutics Announces First Quarter 2009 Financial Results
GlobeNewswire (Mon, May 11)
| | Thu, May 7, 2009 | | • | ORTHOLOGIC CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, May 7)
| | Wed, May 6, 2009 | | • | Capstone Therapeutics to Host Conference Call Discussing First Quarter 2009 Operating Results
GlobeNewswire (Wed, May 6)
| | Wed, Apr 22, 2009 | | • | Capstone Therapeutics Announces Publication of Second Data Group (Elevated Cholesterol) From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire (Wed, Apr 22)
| | Fri, Apr 3, 2009 | | • | Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Pilot Study in Keloid Scarring
GlobeNewswire (Fri, Apr 3)
| | Fri, Mar 13, 2009 | | • | ORTHOLOGIC CORP Files SEC form 10-K, Annual Report
EDGAR Online (Fri, Mar 13)
| | Thu, Mar 5, 2009 | | • | Capstone Therapeutics Announces Publication of First Data Group From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire (Thu, Mar 5)
| | • | Capstone Therapeutics Announces Publication of First Data Group From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire (Thu, Mar 5)
| | Wed, Feb 25, 2009 | | • | Buy This Undervalued Biotech Now
at TheStreet.com (Wed, Feb 25)
| | Tue, Feb 10, 2009 | | • | Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Clinical Trial in Dermal Scarring; Management to Host Teleconference and Webcast Today
GlobeNewswire (Tue, Feb 10)
| | • | ORTHOLOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financia
EDGAR Online (Tue, Feb 10)
| | Thu, Feb 5, 2009 | | • | Capstone Therapeutics to Host Investor Update Teleconference and Webcast February 10, 2009
GlobeNewswire (Thu, Feb 5)
| | Mon, Dec 15, 2008 | | • | Capstone Therapeutics Announces Chrysalin(r) (TP508, Rusalatide Acetate) Scientific Abstracts to be Presented At the American Society for Cell Biology 48th Annual Meeting; Studies Characterize Integrin Interaction and Biologic Activity
GlobeNewswire (Mon, Dec 15)
| | Wed, Dec 10, 2008 | | • | Capstone Therapeutics Announces Positive Safety Results in Primary Endpoint From Second AZX100 Phase 1 Clinical Trial in Dermal Scarring; Pharmacologic Signal Shown in Secondary Endpoints
GlobeNewswire (Wed, Dec 10)
| | Thu, Nov 6, 2008 | | • | ORTHOLOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 6)
|
Add CAPS News to My Yahoo!:
 
| |
|
0.06% Nasdaq 
0.07 (10.88%) 
Headlines
